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Abstract
This policy brief discusses preventive care benefits and cost-sharing included in health insurance provisions of the 
Affordable Care Act (ACA) legislation and highlights some consequences to Americans and the country in terms 
of healthcare costs and value.
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This commentary will address:
1. Cost effects of cost-sharing; 
2. Value-based cost-sharing especially re: preventive care; 
and
3. Reforms in the Affordable Care Act (ACA) legislation. 
Value of cost-sharing
This brief calls into question the extent that consumer cost-
sharing promotes the use of health services that provide 
“value” in terms of benefits and costs. For health services 
to provide value, the cost to the consumer needs to be 
affordable. Dixon and Hertelendy accurately noted the only 
level of prevention with known and documented cost savings 
is primary prevention (1). Examples include lifestyle changes 
like exercise, healthy nutrition, and smoking cessation. 
In contrast, early detection and treatment (aka secondary 
prevention) of a chronic health problem does not usually 
provide cost savings to the individual. Continued and long-
term treatment of chronic disease can become costly when 
recurrent treatment costs are shared by the consumer/patient. 
Thus preventive screenings and other forms of secondary 
prevention can be costly under cost-sharing and thus diminish 
the use of such preventive care. 
Dixon and Hertelendy explain that benefits need to extend 
beyond cost savings to include some level of quality of life 
(e.g. productivity, morale) (1). However, they correctly note 
the difficulty of measuring quality outcomes coupled with 
the fact that outcomes can and do vary among different 
populations. So consumers do not have adequate information 
re: benefits resulting in reliance on costs to assess “value”. 
An important point to also consider re: cost-sharing involves 
differential effects that cost-sharing has on certain consumers/
patients. Are those who are sickest and/or with low incomes 
more likely to reduce their use of services due to cost-sharing? 
There is some evidence from the RAND Health Insurance 
Experiment to indicate that the sickest and low-income 
populations are less likely to use health when costs are shared 
(2). Thus the level of cost-sharing under ACA health plans 
may be disproportionately less valuable to those with greater 
health need; making the legislation less optimal to those  from 
a societal or social welfare perspective (3).
Effects of cost-sharing on health outcomes 
As the costs of care shift to the individual under cost-sharing 
health plans, the value of care can diminish thus resulting in 
less demand for services. Cost-sharing has both short and 
long term effects on health spending. Over 40 years ago, 
the RAND Health Insurance Experiment provided strong 
evidence related to the effects associated with cost-sharing on 
healthcare utilization. For individuals, higher co-payments 
lowered demand for healthcare. These results have been 
corroborated among California public retirees (4).
The effects of cost-sharing on health outcomes are more 
limited. This is due to the modest influence of medical care 
on public and population health. The authors correctly note 
that primary prevention in the form of immunizations, risky 
behavior counseling, cardiovascular prevention etc. can 
lower costs and improve individual and population health 
status. While the authors argue for a preventive approach that 
combines primary and secondary prevention, the absence 
of incentives to enrollees for health promotion and primary 
prevention in the ACA health plans will likely not improve 
America’s public health.
Reforms in the Affordable Care Act legislation
Dixon and Hertelendy assert that insurance providers need 
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to assume a greater part of costs associated with preventive 
care to help reduce individual’s healthcare spending (1). It 
is unclear whether and how less cost-sharing by consumers 
will control overall national costs in the US health system. 
Consider the following:
• Increasing patient cost-sharing does lower individual 
utilization and spending. For individuals, higher co-
payments lowered demand for healthcare (4). However 
it does not take into account health needs of low and 
high users and thus can discourage the vulnerable to 
seek needed care.
• National health spending is directly related to the 
organization and delivery of services.
• Evidence supports that greater managed care penetration 
is associated with slower diffusion of expensive medical 
technology (5). Managing and coordinating care to 
reduce costly duplication has been associated with 
lower system health costs.
An important point to iterate re: the priority goal of the ACA of 
2010 was to improve financial access to healthcare via private 
health insurance plans. This legislation primarily intends to 
offer those without insurance an option for health insurance 
coverage. It provides financial access by subsidizing premiums 
to enrollees based on eligibility. The use of consumer cost-
sharing is likely to reduce individual utilization. 
To a lesser degree the ACA addresses systemic changes 
in the delivery of care. For example, it proffers incentives 
for voluntary changes (e.g. creation of accountable care 
organizations). Without a mandate for widespread 
organizational reform, national healthcare costs are not 
expected to decline. In contrast, cost-sharing is likely to 
have less effect on national health costs and spending than 
organizational and delivery change (3).  
As the health plans from ACA continue to be implemented 
across the country, its promise of increased financial access 
to healthcare will be assessed. However, promises of cost 
reductions based on the ACA legislation and its provisions re: 
preventive care and cost-sharing seem somewhat overstated.  
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